• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates

tetano

Editor, Senior Moderator
BMC Biotechnol. 2017 Nov 10;17(1):79. doi: 10.1186/s12896-017-0396-8.
[h=1]Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.[/h] Kazaks A[SUP]1[/SUP], Lu IN[SUP]2[/SUP], Farinelle S[SUP]2[/SUP], Ramirez A[SUP]3[/SUP], Crescente V[SUP]3[/SUP], Blaha B[SUP]4[/SUP], Ogonah O[SUP]4[/SUP], Mukhopadhyay T[SUP]4[/SUP], de Obanos MP[SUP]5[/SUP], Krimer A[SUP]5[/SUP], Akopjana I[SUP]6[/SUP], Bogans J[SUP]6[/SUP], Ose V[SUP]6[/SUP], Kirsteina A[SUP]6[/SUP], Kazaka T[SUP]6[/SUP], Stonehouse NJ[SUP]7[/SUP], Rowlands DJ[SUP]7[/SUP], Muller CP[SUP]2[/SUP], Tars K[SUP]6,[/SUP][SUP]8[/SUP], Rosenberg WM[SUP]3,[/SUP][SUP]9[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] The lack of a universal influenza vaccine is a global health problem. Interest is now focused on structurally conserved protein domains capable of eliciting protection against a broad range of influenza virus strains. The long alpha helix (LAH) is an attractive vaccine component since it is one of the most conserved influenza hemagglutinin (HA) stalk regions. For an improved immune response, the LAH domain from H3N2 strain has been incorporated into virus-like particles (VLPs) derived from hepatitis B virus core protein (HBc) using recently developed tandem core technology.
[h=4]RESULTS:[/h] Fermentation conditions for recombinant HBc-LAH were established in yeast Pichia pastoris and a rapid and efficient purification method for chimeric VLPs was developed to match the requirements for industrial scale-up. Purified VLPs induced strong antibody responses against both group 1 and group 2 HA proteins in mice.
[h=4]CONCLUSION:[/h] Our results indicate that the tandem core technology is a useful tool for incorporation of highly hydrophobic LAH domain into HBc VLPs. Chimeric VLPs can be successfully produced in bioreactor using yeast expression system. Immunologic data indicate that HBc VLPs carrying the LAH antigen represent a promising universal influenza vaccine component.


[h=4]KEYWORDS:[/h] Influenza vaccine; Long alpha helix; Tandem-core; Virus-like particles; Yeast

PMID: 29126399 DOI: 10.1186/s12896-017-0396-8
Free full text
 
Back
Top Bottom